• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Emerging trends and challenges in multiple sclerosis in Europe: rethinking classification and addressing COVID-19 impact.

作者信息

Korsukewitz Catharina, Wiendl Heinz

机构信息

Department of Neurology with Institute of Translational Neurology, University of Muenster, Muenster, Germany.

出版信息

Lancet Reg Health Eur. 2024 Aug 22;44:101017. doi: 10.1016/j.lanepe.2024.101017. eCollection 2024 Sep.

DOI:10.1016/j.lanepe.2024.101017
PMID:39444704
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11496966/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2905/11496966/e90c76c2a7d6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2905/11496966/e90c76c2a7d6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2905/11496966/e90c76c2a7d6/gr1.jpg

相似文献

1
Emerging trends and challenges in multiple sclerosis in Europe: rethinking classification and addressing COVID-19 impact.欧洲多发性硬化症的新趋势与挑战：重新思考分类并应对新冠疫情的影响
Lancet Reg Health Eur. 2024 Aug 22;44:101017. doi: 10.1016/j.lanepe.2024.101017. eCollection 2024 Sep.
2
Multiple sclerosis: emerging epidemiological trends and redefining the clinical course.多发性硬化症：新出现的流行病学趋势及对临床病程的重新定义
Lancet Reg Health Eur. 2024 Aug 22;44:100977. doi: 10.1016/j.lanepe.2024.100977. eCollection 2024 Sep.
3
COVID-19 and multiple sclerosis: challenges and lessons for patient care.2019冠状病毒病与多发性硬化症：患者护理面临的挑战与经验教训
Lancet Reg Health Eur. 2024 Aug 22;44:100979. doi: 10.1016/j.lanepe.2024.100979. eCollection 2024 Sep.
4
Impact of COVID-19 on multiple sclerosis care and management: Results from the European Committee for Treatment and Research in Multiple Sclerosis survey.COVID-19 对多发性硬化症护理和管理的影响：来自欧洲多发性硬化症治疗与研究委员会调查的结果。
Mult Scler. 2022 Jan;28(1):132-138. doi: 10.1177/13524585211005339. Epub 2021 Mar 25.
5
Rethinking cancer: current challenges and opportunities in cancer research.重新思考癌症：癌症研究中的当前挑战与机遇
Dis Model Mech. 2017 Apr 1;10(4):349-352. doi: 10.1242/dmm.030007.
6
The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis.COVID-19 大流行对进展性多发性硬化症患者的情绪影响。
J Neurol. 2021 May;268(5):1598-1607. doi: 10.1007/s00415-020-10160-7. Epub 2020 Aug 19.
7
Emerging evidence-based physical rehabilitation for multiple sclerosis - towards an inventory of current content across Europe.新兴基于证据的多发性硬化症康复治疗 - 探索欧洲当前的现状。
Health Qual Life Outcomes. 2010 Jul 28;8:76. doi: 10.1186/1477-7525-8-76.
8
World-wide trends in multiple sclerosis mortality.全球多发性硬化症死亡率趋势。
Neuroepidemiology. 1989;8(2):56-67. doi: 10.1159/000110167.
9
Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study.实时评估多发性硬化症患者中的 COVID-19 流行情况：一项多中心的欧洲研究。
Neurol Sci. 2020 Jul;41(7):1647-1650. doi: 10.1007/s10072-020-04519-x. Epub 2020 Jul 2.
10
Exploring COVID-19 experiences for persons with multiple sclerosis and carers: An Australian qualitative study.探索 COVID-19 对多发性硬化症患者及其照顾者的影响：一项澳大利亚定性研究。
Health Expect. 2023 Apr;26(2):785-794. doi: 10.1111/hex.13704. Epub 2023 Jan 13.

引用本文的文献

1
Current challenges in secondary progressive multiple sclerosis: diagnosis, activity detection and treatment.继发进展型多发性硬化的当前挑战：诊断、活动检测与治疗
Front Immunol. 2025 Mar 21;16:1543649. doi: 10.3389/fimmu.2025.1543649. eCollection 2025.
2
Exosomes as Biomarkers and Therapeutic Agents in Neurodegenerative Diseases: Current Insights and Future Directions.外泌体作为神经退行性疾病的生物标志物和治疗剂：当前见解与未来方向
Mol Neurobiol. 2025 Mar 17. doi: 10.1007/s12035-025-04825-5.

本文引用的文献

1
COVID-19 and multiple sclerosis: challenges and lessons for patient care.2019冠状病毒病与多发性硬化症：患者护理面临的挑战与经验教训
Lancet Reg Health Eur. 2024 Aug 22;44:100979. doi: 10.1016/j.lanepe.2024.100979. eCollection 2024 Sep.
2
Multiple sclerosis.多发性硬化症。
Lancet. 2024 Jan 13;403(10422):183-202. doi: 10.1016/S0140-6736(23)01473-3. Epub 2023 Nov 7.
3
Harmonizing Definitions for Progression Independent of Relapse Activity in Multiple Sclerosis: A Systematic Review.统一多发性硬化症中与复发活动无关的进展的定义：一项系统评价
JAMA Neurol. 2023 Nov 1;80(11):1232-1245. doi: 10.1001/jamaneurol.2023.3331.
4
ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs.ECTRIMS/EAN 关于多发性硬化症患者接种疫苗的共识：在高度活跃的免疫治疗药物时代改进免疫策略。
Mult Scler. 2023 Jul;29(8):904-925. doi: 10.1177/13524585231168043. Epub 2023 Jun 9.
5
Safety of COVID-19 vaccines in multiple sclerosis: A systematic review and meta-analysis.COVID-19 疫苗在多发性硬化症中的安全性：系统评价和荟萃分析。
Mult Scler. 2023 Apr;29(4-5):585-594. doi: 10.1177/13524585221150881. Epub 2023 Feb 1.
6
Changes in prognosis of the Danish multiple sclerosis population over time.丹麦多发性硬化症患者预后的变化趋势。
Mult Scler. 2022 Dec;28(14):2190-2201. doi: 10.1177/13524585221110582. Epub 2022 Jul 13.
7
How patients with multiple sclerosis acquire disability.多发性硬化症患者如何致残。
Brain. 2022 Sep 14;145(9):3147-3161. doi: 10.1093/brain/awac016.
8
Vaccine hesitancy among people with multiple sclerosis.多发性硬化症患者中的疫苗犹豫。
Mult Scler Relat Disord. 2021 Nov;56:103236. doi: 10.1016/j.msard.2021.103236. Epub 2021 Sep 2.